Telehealth Didn’t Break the Bank—And the Data Prove It

Why It Matters

The findings reassure policymakers and payers that permanent telehealth coverage is unlikely to inflate near‑term health‑care costs, supporting arguments for maintaining expanded virtual‑care benefits.

Key Takeaways

• Study of 3.04 M adults found telehealth didn't raise total spending.
• High telemedicine regions had 2.4% fewer visits, not statistically significant.
• Federal telehealth flexibilities expire end‑2027, prompting policy debate.
• Rural areas saw slight visit increase, but spending impact remained neutral.

Pulse Analysis

The telehealth boom, catalyzed by emergency regulatory waivers in March 2020, reshaped how Americans accessed care. By eliminating geographic restrictions and guaranteeing payment parity, policymakers unlocked a rapid shift from 0.26% to over 40% of ambulatory visits being virtual in the most aggressive markets. This natural experiment gave researchers a rare, large‑scale dataset to test the long‑standing fear that easier access would generate wasteful, low‑value utilization and balloon health‑care expenditures.

UCLA investigators applied a rigorous difference‑in‑differences framework, contrasting the top quintile of telemedicine adopters with the bottom quintile across Medicare fee‑for‑service, Medicare Advantage, Medicaid, dual‑eligible, and commercial plans. Across 120 million visits, total spend remained flat, with high‑adoption regions showing a marginal 0.5% spending dip that was statistically indistinguishable from zero. Even when broken down by geography, income, or payer, the null result persisted, reinforcing the robustness of the conclusion. A parallel check on injury‑related spending—an area unlikely to be substituted by virtual care—showed no change, further validating the methodology.

For insurers, employers, and legislators, the study offers evidence that extending telehealth flexibilities does not pose a fiscal threat. As the current waivers lapse at the end of 2027, the data provide a factual counterweight to critics who warn of a “telehealth cost explosion.” However, the analysis stops short of assessing care quality or health outcomes, leaving a gap that future research must fill. Nonetheless, the consistency of the null findings across payer types and regions strengthens the case for preserving, and potentially expanding, virtual‑care coverage as a cost‑neutral component of the American health‑care system.